Papers
4
Total Citations
310
H-Index
3
About
Menghang Xia is a leading researcher in computational and high-throughput toxicology, whose work has been instrumental in modernizing how scientists assess the safety of environmental chemicals and pharmaceutical compounds. Best known for his foundational contributions to the Tox21 program — a collaborative U.S. federal initiative to predict chemical toxicity using in vitro assays — Xia helped transform a visionary concept into a fully operational robotic screening platform capable of evaluating thousands of compounds simultaneously. His 2013 paper describing this platform has accumulated over 255 citations, reflecting its outsized influence on the field. Xia's research addresses a critical challenge: traditional animal-based toxicity testing is slow, costly, and often poorly predictive of human outcomes. His work on high-throughput screening methods and the Tox21 chemical library has advanced both chemical prioritization and mechanistic toxicology. More recently, Xia has expanded into stem cell biology, developing scalable methods to differentiate human pluripotent stem cells into hypothalamic arcuate neurons, opening new avenues for modeling metabolic and reproductive disorders. Across his career, Xia's interdisciplinary approach bridges robotics, toxicology, and human cell biology to drive safer and more efficient chemical risk assessment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4